Tag
Sushil Suri
2 articles
Morepen Q1 Revenue Up 34%, PAT Soars 394% YoY
Morepen Laboratories reported Q1 FY27 revenue of ₹575.31 Cr, up 34% YoY, and PAT of ₹56.35 Cr, up 394% YoY.
EBITDA grew 207% YoY to ₹87.72 Cr with margin expansion to 15.25% from 6.65% in Q1 FY26.
The
Morepen Laboratories Q1 FY27 Net Profit Rises 425% YoY
Board approved Q1 FY27 unaudited standalone net profit of ₹53.99 Cr, up 425% YoY, and consolidated net profit of ₹56.40 Cr.
Declared record date of 19-Sep-2026 for final dividend for FY26, subject to